{"entity":{"type":"insider","cik":"0001853109","url":"/insider/0001853109","json_url":"/insider/0001853109.json","name":"Derakhshan Behrad","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":8,"first":"2023-05-03","last":"2026-08-14","span_basis":"filed_date"},"name_variants":[{"name":"Derakhshan Behrad","source":"filing","n_filings":8,"first_seen":"2023-05-03","last_seen":"2026-08-14"}],"transactions":[{"id":9296489,"accession":"0001853109-26-000001","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001853109-26-000001","line_url":"/filing/0001853109-26-000001","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853109","owner_name":"Derakhshan Behrad","owner_display_name":"Derakhshan Behrad","owner_url":"/insider/0001853109","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5100.0,"shares_display":"5,100","price_per_share":43.80863796078432,"price_display":"43.81","price_state":"stated","total_value":223424.0536,"total_display":"223,424.05","total_whole":"223,424","shares_owned_after":31826.0,"shares_owned_after_display":"31,826","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-12","filed_date":"2026-08-14","scope":"insider","n_lines":4},{"id":4651475,"accession":"0001562180-25-005798","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-005798","line_url":"/filing/0001562180-25-005798#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853109","owner_name":"Derakhshan Behrad","owner_display_name":"Derakhshan Behrad","owner_url":"/insider/0001853109","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2491.0,"shares_display":"2,491","price_per_share":13.3924,"price_display":"13.39","price_state":"stated","total_value":33360.4684,"total_display":"33,360.47","total_whole":"33,360","shares_owned_after":23645.0,"shares_owned_after_display":"23,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-14","scope":"insider"},{"id":4473759,"accession":"0001562180-25-003656","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-003656","line_url":"/filing/0001562180-25-003656#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853109","owner_name":"Derakhshan Behrad","owner_display_name":"Derakhshan Behrad","owner_url":"/insider/0001853109","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1691.0,"shares_display":"1,691","price_per_share":16.4542,"price_display":"16.45","price_state":"stated","total_value":27824.0522,"total_display":"27,824.05","total_whole":"27,824","shares_owned_after":20355.0,"shares_owned_after_display":"20,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-02","filed_date":"2025-05-07","scope":"insider"},{"id":4967030,"accession":"0001562180-25-001024","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-001024","line_url":"/filing/0001562180-25-001024#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853109","owner_name":"Derakhshan Behrad","owner_display_name":"Derakhshan Behrad","owner_url":"/insider/0001853109","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.03,"price_display":"30.03","price_state":"stated","total_value":300300.0,"total_display":"300,300.00","total_whole":"300,300","shares_owned_after":16837.0,"shares_owned_after_display":"16,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-05","filed_date":"2025-02-07","scope":"insider"},{"id":2565920,"accession":"0001562180-24-006943","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-006943","line_url":"/filing/0001562180-24-006943#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853109","owner_name":"Derakhshan Behrad","owner_display_name":"Derakhshan Behrad","owner_url":"/insider/0001853109","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42068.0,"shares_display":"42,068","price_per_share":29.0276,"price_display":"29.03","price_state":"stated","total_value":1221133.0768,"total_display":"1,221,133.08","total_whole":"1,221,133","shares_owned_after":15121.0,"shares_owned_after_display":"15,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-20","filed_date":"2024-09-24","scope":"insider"},{"id":2288785,"accession":"0001562180-24-003828","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-003828","line_url":"/filing/0001562180-24-003828#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853109","owner_name":"Derakhshan Behrad","owner_display_name":"Derakhshan Behrad","owner_url":"/insider/0001853109","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1718.0,"shares_display":"1,718","price_per_share":18.91,"price_display":"18.91","price_state":"stated","total_value":32487.38,"total_display":"32,487.38","total_whole":"32,487","shares_owned_after":13422.0,"shares_owned_after_display":"13,422","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-02","filed_date":"2024-05-03","scope":"insider"},{"id":2789533,"accession":"0001562180-24-001226","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-24-001226","line_url":"/filing/0001562180-24-001226#line-6","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853109","owner_name":"Derakhshan Behrad","owner_display_name":"Derakhshan Behrad","owner_url":"/insider/0001853109","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":20.0436,"price_display":"20.04","price_state":"stated","total_value":96209.28,"total_display":"96,209.28","total_whole":"96,209","shares_owned_after":7020.0,"shares_owned_after_display":"7,020","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-09","filed_date":"2024-02-09","scope":"insider"},{"id":2789523,"accession":"0001562180-24-001226","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-24-001226","line_url":"/filing/0001562180-24-001226#line-4","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853109","owner_name":"Derakhshan Behrad","owner_display_name":"Derakhshan Behrad","owner_url":"/insider/0001853109","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":20.0106,"price_display":"20.01","price_state":"stated","total_value":92048.76,"total_display":"92,048.76","total_whole":"92,049","shares_owned_after":7020.0,"shares_owned_after_display":"7,020","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-08","filed_date":"2024-02-09","scope":"insider"},{"id":2789513,"accession":"0001562180-24-001226","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-001226","line_url":"/filing/0001562180-24-001226#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853109","owner_name":"Derakhshan Behrad","owner_display_name":"Derakhshan Behrad","owner_url":"/insider/0001853109","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","total_whole":"12,000","shares_owned_after":7020.0,"shares_owned_after_display":"7,020","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-07","filed_date":"2024-02-09","scope":"insider"},{"id":8128773,"accession":"0001562180-23-003923","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-23-003923","line_url":"/filing/0001562180-23-003923#line-2","is_derivative":false,"issuer_cik":"0001710072","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001710072","owner_cik":"0001853109","owner_name":"Derakhshan Behrad","owner_display_name":"Derakhshan Behrad","owner_url":"/insider/0001853109","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1747.0,"shares_display":"1,747","price_per_share":8.9049,"price_display":"8.90","price_state":"stated","total_value":15556.8603,"total_display":"15,556.86","total_whole":"15,557","shares_owned_after":7020.0,"shares_owned_after_display":"7,020","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-02","filed_date":"2023-05-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001710072","name":"Edgewise Therapeutics, Inc.","url":"/issuer/0001710072","role":"Officer (Chief Business Officer)","n_filings":8,"first_seen":"2023-05-03","last_seen":"2026-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001853109","retrieved_at":"2026-08-26T02:46:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}